Therapeutic Regulation of VE-cadherin With a Novel Oligonucleotide Drug for Diabetic Eye Complications Using Retinopathy Mouse Models

Diabetologia - Germany
doi 10.1007/s00125-018-4770-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

New Therapeutic Approaches in Diabetic Retinopathy

Review of Diabetic Studies
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2016English

Choosing Preclinical Study Models of Diabetic Retinopathy: Key Problems for Consideration

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2019English

Microaneurysms Detection Using Blob Analysis for Diabetic Retinopathy

International Journal of Integrated Engineering
Mechanics of MaterialsElectronic EngineeringIndustrialMechanical EngineeringMaterials ScienceCivilManufacturing EngineeringElectricalStructural Engineering
2019English

Ocular Axial Length and Diabetic Retinopathy: The Kailuan Eye Study

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Triamcinolone for Diabetic Retinopathy

Revista Brasileira de Oftalmologia
OphthalmologySurgery
2015English

Pdb4 - The Effect of Statins Usage on Diabetic Eye Complications

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Screening for Diabetic Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy